Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial Academic Article Article uri icon

Overview

MeSH Major

  • Colorectal Neoplasms
  • Peritoneal Neoplasms

abstract

  • Merck Sharp and Dohme.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(14)60958-2

PubMed ID

  • 25034862

Additional Document Info

start page

  • 1109

end page

  • 17

volume

  • 384

number

  • 9948